{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:04:21Z","timestamp":1762542261991},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T00:00:00Z","timestamp":1395273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00063-013-0308-1","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T13:52:01Z","timestamp":1395150721000},"page":"162-166","source":"Crossref","is-referenced-by-count":8,"title":["Pharmakokinetische und pharmakodynamische Aspekte bei der Antibiotikatherapie"],"prefix":"10.1007","volume":"109","author":[{"given":"R.","family":"Bellmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"308_CR1","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/AAC.41.11.2424","volume":"41","author":"Allaouchiche","year":"1997","unstructured":"Allaouchiche B, Breilh D, Jaumain H et al (1997) Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 41:2424\u20132427","journal-title":"Antimicrob Agents Chemother"},{"key":"308_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/157488407779422311","volume":"2","author":"Bellmann","year":"2007","unstructured":"Bellmann R (2007) Clinical pharmacokinetics of systemically administered antimycotics. Curr Clin Pharmacol 2:37\u201358","journal-title":"Curr Clin Pharmacol"},{"key":"308_CR3","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.2174\/13816128113199990332","volume":"19","author":"Bellmann","year":"2013","unstructured":"Bellmann R (2013) Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis. Curr Pharm Des 19:3629\u20133647","journal-title":"Curr Pharm Des"},{"key":"308_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5414\/CPP40142","volume":"40","author":"Bellmann","year":"2002","unstructured":"Bellmann R, Egger P, Gritsch W et al (2002) Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 40:142\u2013149","journal-title":"Int J Clin Pharmacol Ther"},{"key":"308_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1563-2571.2002.02017.x","volume":"29","author":"Bellmann","year":"2002","unstructured":"Bellmann R, Egger P, Gritsch W et al (2002) Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. Acta Med Austriaca 29:112\u2013116","journal-title":"Acta Med Austriaca"},{"key":"308_CR6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jac\/dkg139","volume":"51","author":"Bellmann","year":"2003","unstructured":"Bellmann R, Egger P, Gritsch W et al (2003) Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration. J Antimicrob Chemother 51:671\u2013681","journal-title":"J Antimicrob Chemother"},{"key":"308_CR7","first-page":"243","volume":"48","author":"Bellmann","year":"2010","unstructured":"Bellmann R, Falkensammer G, Seger C et al (2010) Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 48:243\u2013249","journal-title":"Int J Clin Pharmacol Ther"},{"key":"308_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.idc.2007.07.004","volume":"21","author":"Bergman","year":"2007","unstructured":"Bergman SJ, Speil C, Short M et al (2007) Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations. Infect Dis Clin North Am 21:821\u2013846","journal-title":"Infect Dis Clin North Am"},{"key":"308_CR9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ndt\/gfi284","volume":"21","author":"Bergner","year":"2006","unstructured":"Bergner R, Hoffmann M, Riedel KD et al (2006) Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800\u00a0mg. Nephrol Dial Transplant 21:1019\u20131023","journal-title":"Nephrol Dial Transplant"},{"key":"308_CR10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s001340051018","volume":"25","author":"Boereboom","year":"1999","unstructured":"Boereboom FT, Ververs FF, Blankestijn PJ et al (1999) Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Intensive Care Med 25:1100\u20131104","journal-title":"Intensive Care Med"},{"key":"308_CR11","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1097\/CCM.0b013e3181aab3d0","volume":"37","author":"Choi","year":"2009","unstructured":"Choi G, Gomersall CD, Tian Q et al (2009) Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 37:2268\u20132282","journal-title":"Crit Care Med"},{"key":"308_CR12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1345\/aph.1P160","volume":"44","author":"Curkovic","year":"2010","unstructured":"Curkovic I, L\u00fcthi B, Franzen D et al (2010) Trimethoprim\/Sulfamethoxazole pharmacokinetics in two patients undergoing continuous venovenous hemodiafiltration. Ann Pharmacother 44:1669\u20131672","journal-title":"Ann Pharmacother"},{"key":"308_CR13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/jac\/dkm349","volume":"60","author":"Fuhrmann","year":"2007","unstructured":"Fuhrmann V, Schenk P, Jaeger W et al (2007) Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration. J Antimicrob Chemother 60:1085\u20131090","journal-title":"J Antimicrob Chemother"},{"key":"308_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/dkl251","volume":"58","author":"Gattringer","year":"2006","unstructured":"Gattringer R, Meyer B, Heinz G et al (2006) Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration. J Antimicrob Chemother 58:367\u2013371","journal-title":"J Antimicrob Chemother"},{"key":"308_CR15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jac\/dkq545","volume":"66","author":"Leitner","year":"2011","unstructured":"Leitner JM, Meyer B, Fuhrmann V et al (2011) Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration. J Antimicrob Chemother 66:880\u2013884","journal-title":"J Antimicrob Chemother"},{"key":"308_CR16","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.49.11.4814-4815.2005","volume":"49","author":"Li","year":"2005","unstructured":"Li J, Rayner CR, Nation RL et al (2005) Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 49:4814\u20134815","journal-title":"Antimicrob Agents Chemother"},{"key":"308_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000070997","volume":"26","author":"Meyer","year":"2003","unstructured":"Meyer B, Ahmed el Gendy S, Delle Karth G et al (2003) How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin. Kidney Blood Press Res 26:135\u2013140","journal-title":"Kidney Blood Press Res"},{"key":"308_CR18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jac\/dki133","volume":"56","author":"Meyer","year":"2005","unstructured":"Meyer B, Kornek GV, Nikfardjam M et al (2005) Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration. J Antimicrob Chemother 56:172\u2013179","journal-title":"J Antimicrob Chemother"},{"key":"308_CR19","first-page":"5","volume":"8","author":"Pea","year":"2013","unstructured":"Pea F (2013) Plasma pharmacokinetics of antimicrobial agents in critically ill patients. Curr Clin Pharmacol 8:5\u201312","journal-title":"Curr Clin Pharmacol"},{"key":"308_CR20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","volume":"44","author":"Pea","year":"2005","unstructured":"Pea F, Viale P, Furlanut M (2005) Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet 44:1009\u20131034","journal-title":"Clin Pharmacokinet"},{"key":"308_CR21","first-page":"25","volume":"8","author":"Pereira","year":"2013","unstructured":"Pereira JM, Paiva JA (2013) Antimicrobial drug interactions in the critically ill patients. Curr Clin Pharmacol 8:25\u201338","journal-title":"Curr Clin Pharmacol"},{"key":"308_CR22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","volume":"37","author":"Roberts","year":"2009","unstructured":"Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37:840\u2013851 (quiz 859)","journal-title":"Crit Care Med"},{"key":"308_CR23","first-page":"13","volume":"8","author":"Smuszkiewicz","year":"2013","unstructured":"Smuszkiewicz P, Sza\u0142ek E, Tomczak H et al (2013) Continuous infusion of antibiotics in critically ill patients. Curr Clin Pharmacol 8:13\u201324","journal-title":"Curr Clin Pharmacol"},{"key":"308_CR24","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.41.12.2640","volume":"41","author":"Tegeder","year":"1997","unstructured":"Tegeder I, Bremer F, Oelkers R et al (1997) Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration. Antimicrob Agents Chemother 41:2640\u20132645","journal-title":"Antimicrob Agents Chemother"},{"key":"308_CR25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/AAC.42.9.2417","volume":"42","author":"Thalhammer","year":"1998","unstructured":"Thalhammer F, Schenk P, Burgmann H et al (1998) Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration. Antimicrob Agents Chemother 42:2417\u20132420","journal-title":"Antimicrob Agents Chemother"},{"key":"308_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/49.1.129","volume":"49","author":"Traunm\u00fcller","year":"2002","unstructured":"Traunm\u00fcller F, Schenk P, Mittermeyer C et al (2002) Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients. J Antimicrob Chemother 49:129\u2013134","journal-title":"J Antimicrob Chemother"},{"key":"308_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/48.6.881","volume":"48","author":"Valtonen","year":"2001","unstructured":"Valtonen M, Tiula E, Takkunen O et al (2001) Elimination of the piperacillin\/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure. J Antimicrob Chemother 48:881\u2013885","journal-title":"J Antimicrob Chemother"},{"key":"308_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccc.2010.09.006","volume":"27","author":"Varghese","year":"2011","unstructured":"Varghese JM, Roberts JA, Lipman J (2011) Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 27:19\u201334","journal-title":"Crit Care Clin"},{"key":"308_CR29","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AAC.00335-13","volume":"57","author":"Weiler","year":"2013","unstructured":"Weiler S, Seger C, Pfisterer H et al (2013) Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother 57:4053\u20134057","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-013-0308-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0308-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T15:38:02Z","timestamp":1565278682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-013-0308-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1007\/s00063-013-0308-1","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}